N-acetylneuraminic acid compounds of formula as follows, a pharmaceutical composition, a preparation method and uses thereof are disclosed. The compounds can inhibit surface neuraminidase of influenza virus, thus can be used for resisting influenza virus, especially, for treating infections caused by the influenza virus which has resistance to other anti-flu drugs such as zanamivir and oseltamivir.